Phase II trial of combined 5-fluorouracil plus doxorubicin plus cisplatin (FAP regimen) in advanced gastric carcinoma

Cancer Treat Rep. 1987 Dec;71(12):1301-2.

Authors

P Rougier¹, J P Droz, C Theodore, G Piot, P Herait, P Ruffie, P Carde, E Cvitkovic

Affiliation

¹ Département de Médecine, Institut Gustave-Roussy, Villejuif, France.

PMID: 3690544

No abstract available

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma / drug therapy*
Cisplatin / administration & dosage
Cisplatin / adverse effects
Doxorubicin / administration & dosage
Doxorubicin / adverse effects
Drug Administration Schedule
Drug Evaluation / adverse effects
Fluorouracil / administration & dosage
Fluorouracil / adverse effects
Humans
Stomach Neoplasms / drug therapy*

Substances

Doxorubicin
Cisplatin
Fluorouracil